Tag: pharmacokinetics
-

High-Dose Rifampin Shows No Advantage for Tuberculosis Meningitis, Study Finds
Background: Rethinking Rifampin Dosing in TB Meningitis Tuberculosis meningitis (TBM) is a severe form of TB that affects the brain and central nervous system. Clinicians have debated whether increasing the dose of rifampin, a cornerstone anti-TB drug, could improve drug penetration into the cerebrospinal fluid and, in turn, patient outcomes. Earlier small studies and theoretical…
